CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Determination Of Immune Cell Composition And CAR-T Cells

  Discover a system that automates CAR-T cell production using flow cytometry and analyzers for precise monitoring as well as learn about the sample preparation, instrument setup, and data analysis.

• Lentiviral Vector Bioproduction Follow-Up Tool

  Explore a new optical device that performs real-time, user-friendly, and label-free measurements of lentiviral vector physical titer and size distribution.

• Ensuring cGMP Compliance In Cell And Gene Therapy Manufacturing

  Discover how adhering to strict GMP guidelines and advanced equipment design ensures that complex, sterile cell and gene therapies are safely and effectively delivered.

• Advancing An Integrated Biopharma Workflow Strategy

  Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

• Leveraging Droplet Digital PCR For Accurate Viral Titer Measurement

  Accurately measuring viral titer is a key metric throughout gene therapy development, whether you are in the early stage, scaling production, or running assays for quality control release.

• Automated Library Prep For Nanopore Human Whole Genome Sequencing

  Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.

• ATMP Cryopreservation Done Right - Best Practice In Small Volume Cryo-Freezing

  Explore best practices for cryopreserving small-volume advanced therapy medicinal products (ATMPs), emphasizing sterility, cell viability, and efficiency using innovative single-use systems and aseptic connectors.

• Efficient Late-Stage Development Of Biologics

  Reducing biologics manufacturing costs requires strategic late-stage process development, yield optimization, scale-up, and raw material substitution—all while maintaining product quality and regulatory compliance.

• Alternative Two-Step Mixed-Mode Approach To A mAb Purification Process

  Two post–Protein A capture two-step mAb processes were developed and compared to an archetypical three-step mAb purification process using two IEX steps after Protein A capture.

• Predicting Antibody-Dependent Cell-Mediated Cytotoxicity

  We developed and validated a dual screening procedure (genotype and phenotype) for Lonza human peripheral blood mononuclear cells (PBMCs) to identify donors with high ADCC potential.